Literature DB >> 9087350

Arteritis following intra-arterial chemotherapy for liver tumors.

L Belli1, G Magistretti, G P Puricelli, G Damiani, E Colombo, G P Cornalba.   

Abstract

Primary and metastatic tumors of the liver can be treated successfully with transcatheter chemoembolization (TACE) during selective arterial catheterism. Arteritis is a possible referred side effect which can lead to tortuosity of the arteries, stenosis and occlusion of vessels. In our hospitals 117 consecutive patients were treated with TACE from January 1990 to December 1992; 61 patients were affected by hepatocellular carcinoma (HCC) and 56 were affected by metastases from colorectal carcinoma. Each patient received from 1 to 4 treatments at monthly intervals using epirubicin/Lipiodol ultrafluid (E/LUF) or a mixture of epirubicin and mitomicin C (MC)/LUF and followed by gelatine sponge injection in the hepatic artery. Selective angiography performed 30-62 days after the first chemoembolization showed artery stenosis in 7 patients and thrombosis in 2 cases related to toxic arteritis due to chemoembolization. Reports about arteritis during TACE treatments are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9087350     DOI: 10.1007/s003300050159

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  10 in total

Review 1.  Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies.

Authors:  Khairuddin Memon; Robert J Lewandowski; Ahsun Riaz; Riad Salem
Journal:  Curr Treat Options Oncol       Date:  2012-09

2.  Tumor Growth Suppression With Novel Intra-arterial Chemotherapy Using Epirubicin-entrapped Water-in-oil-in-water Emulsion In Vivo.

Authors:  Hironobu Yanagie; Takashi Fujino; Masashi Yanagawa; Toshimitsu Terao; Takashi Imagawa; Mitsuteru Fujihara; Yasuyuki Morishita; Ryouji Mizumachi; Yuuji Murata; Novriana Dewi; Yuuya Ono; Ichiro Ikushima; Koji Seguchi; Masashi Nagata; Yasumasa Nonaka; Yoshitaka Furuya; Tomoyuki Hisa; Takeshi Nagasaki; Kazuhiko Arimori; Tadao Nakashima; Takumichi Sugihara; Kazuhiro Kakimi; Minoru Ono; Jun Nakajima; Masazumi Eriguchi; Shushi Higashi; Hiroyuki Takahashi
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

Review 3.  Hepatocellular carcinoma.

Authors:  S Badvie
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

4.  Dual-balloon infusion microcatheter for selective drug-eluting bead transarterial chemoembolization: initial feasibility study.

Authors:  Wayne L Monsky; Siddharth A Padia; Andrew Hal Hardy
Journal:  Diagn Interv Radiol       Date:  2017 Nov-Dec       Impact factor: 2.630

5.  Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver.

Authors:  Timm Kirchhoff; Lars Zender; Sonja Merkesdal; Bernd Frericks; Nisar Malek; Joerg Bleck; Stefan Kubicka; Stefan Baus; Ajay Chavan; Michael-P Manns; Michael Galanski
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

Review 6.  Chemoembolization and radioembolization for hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-26       Impact factor: 11.382

7.  Angiographic evaluation of hepatic arterial injury after cisplatin and Gelfoam-based transcatheter arterial chemoembolization for hepatocellular carcinoma in a 205 patient cohort during a 6-year follow-up.

Authors:  C H Suh; J H Shin; H M Yoon; H-K Yoon; G-Y Ko; D-I Gwon; J-H Kim; K-B Sung
Journal:  Br J Radiol       Date:  2014-06-27       Impact factor: 3.039

8.  Sustained multiple organ ischaemia after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

Authors:  Young Woon Kim; Jung Hyun Kwon; Soon Woo Nam; Jeong Won Jang; Hyun Suk Jung; Yu Ri Shin; Eun Su Park; Dong Jae Shim
Journal:  Exp Ther Med       Date:  2017-11-22       Impact factor: 2.447

9.  Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.

Authors:  Robert Cg Martin; Ken Robbins; Dana Tomalty; Ryan O'Hara; Petar Bosnjakovic; Radek Padr; Miloslav Rocek; Frantisek Slauf; Alexander Scupchenko; Cliff Tatum
Journal:  World J Surg Oncol       Date:  2009-11-03       Impact factor: 2.754

Review 10.  Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities.

Authors:  Hamid Chalian; James K O'Donnell; Michael Bolen; Prabhakar Rajiah
Journal:  Insights Imaging       Date:  2016-05-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.